Literature DB >> 7115010

Smooth pursuit eye tracking impairment: relation to other 'markers' of schizophrenia and psychologic correlates.

L J Siever, R J Haier, R D Coursey, A J Sostek, D L Murphy, P S Holzman, M S Buchsbaum.   

Abstract

Smooth pursuit eye tracking impairment has been observed in the major psychoses, particularly schizophrenia. To understand better the relationship of smooth pursuit disruption to personality dispositions linked to psychiatric syndromes and to two other "marker variables" associated with psychosis (low platelet monoamine oxidase [MAO] activity and poor performance on the continuous performance task [CPT]), we studied the psychologic, biochemical, and psychophysiologic correlates of impaired smooth pursuit tracking in two nonpsychiatric patient populations. One sample consisted of 67 volunteers screened for extreme values in a distribution of platelet MAO activities, and the second included 29 volunteers screened for extreme scores on the CPT. An aggregate of about 5% of both samples showed clearly dysfunctional smooth pursuit. Eye tracking dysfunction did not seem to be related to either MAO or CPT performance in either study. Both studies were consistent in showing that subjects with impaired smooth pursuit eye tracking had a psychologic profile characterized particularly by social introversion.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7115010     DOI: 10.1001/archpsyc.1982.04290090011003

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  3 in total

1.  Psychobiology of the borderline disorders--a heuristic approach.

Authors:  M L Zarr
Journal:  Psychiatr Q       Date:  1984

2.  Familial and sporadic schizophrenics: a study of pursuit eye movements.

Authors:  R Sharan; S Chaterjee; N Janakiramaiah; B N Gangadhar
Journal:  Indian J Psychiatry       Date:  1992-07       Impact factor: 1.759

3.  Eye tracking, schizophrenic symptoms, and schizotypal personality disorder.

Authors:  R S Keefe; L J Siever; R C Mohs; A E Peterson; T R Mahon; R L Bergman; K L Davis
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.